BAYER AG
- Pharmaceutical Sales 2010
-
Worlwide: 10.908 billion EURO (Bayer HealthCare Pharmaceuticals)
Bayer HealthCare Germany: 1.101 billion Euro
- Product Range
-
General Medicine
Pharmaceuticals to treat hypertension, stroke prevention in case of atrial fibrillation, preparations for the prevention of venous thromboembolisms, antibiotics to fight respiratory, urinary and surgical infections, treatments for testosterone deficiency and erectile dysfunction in men.
Specialty Medicine
Products for treating multiple sclerosis (MS), the treatment of the bleeding disorder hemophilia A and cancer
Women’s Healthcare
Both oral and non-oral contraceptives, products for menopause management as well as gynecological therapies. - Key Research Areas
- Ophthalmology, cardiovascular and blood diseases, cancer, diagnostic imaging, applied research and life cycle management in hemophilia, Multiple Sclerosis
- R&D Expenditure 2010
-
worldwide: 1.75 billion EURO (Bayer HealthCare Pharmaceuticals)
- Employees in the Pharmaceuticals Division 2010
-
worldwide: 38,000 (Bayer HealthCare Pharmaceuticals)
Bayer HealthCare in Germany: 12.976
(All data based on corporate information, as of: 01/2012)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page